-
Taxonomy & unit
-
us-gaap: CAD and USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Intellipharmaceutics International Inc. annual/quarterly Operating Income (Loss) history and growth rate from 2014 to 2018.
- Intellipharmaceutics International Inc. Operating Income (Loss) for the quarter ending May 31, 2017 was -CA$1.75M, a 8.13% increase year-over-year.
- Intellipharmaceutics International Inc. annual Operating Income (Loss) for 2018 was -CA$13.3M, a 61.2% decline from 2017.
- Intellipharmaceutics International Inc. annual Operating Income (Loss) for 2017 was -CA$8.27M, a 16.1% increase from 2016.
- Intellipharmaceutics International Inc. annual Operating Income (Loss) for 2016 was -CA$9.85M, a 38.5% decline from 2015.
Operating Income (Loss), Annual (CAD)
Operating Income (Loss), YoY Annual Growth (%)